A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division. As reported in Oncogene, tumors treated with the ...
Sep 4, 2023
0
172
When fighting disease, our immune cells need to reach their target quickly. Researchers at the Institute of Science and Technology Austria (ISTA) have now discovered that immune cells actively generate their own guidance ...
Sep 1, 2023
0
160
It's always a good idea to use caution when having some summer fun—and that includes preventing burns from barbecues and other heat sources.
Aug 28, 2023
0
2
A research group has found that novel autoantibodies that had been found to cause thrombosis and other conditions in joint research conducted by Kobe and Osaka universities in 2015, are also implicated in pregnancy disorders, ...
Aug 28, 2023
0
29
Researchers from MIT Lincoln Laboratory and their collaborators at the Massachusetts General Hospital (MGH) Center for Ultrasound Research and Translation (CURT) have developed a new medical imaging device: the Noncontact ...
Aug 24, 2023
0
11
For more than 100 years, it has been believed that sunlight and vitamin D deficiency were associated with the risk for many deadly cancers including colorectal, prostate and breast. But some scientists remained skeptical ...
Aug 22, 2023
0
4
According to new research in the journal Immunity, T cells have a nuclear receptor doing something very odd—but very important—to help them fight pathogens and destroy cancer cells. This receptor, called retinoic acid ...
Aug 18, 2023
0
68
Scientists have found a potential new drug target for untreatable fatty liver disease in humans, according to a study published today in eLife.
Aug 15, 2023
0
3
Parents and caregivers are being advised to immediately stop using La-La-Me Infant Loungers because they pose a risk to babies of suffocation and falling.
Aug 11, 2023
0
1
Published online ahead of print in the journal Oncogene, a study led by Josep Villanueva, an Investigator at the Vall d'Hebron Institute of Oncology (VHIO), shows that the receptor for advanced glycation end-product (RAGE) ...
Aug 8, 2023
0
1
